At Exonics, we are building a collaborative team of exceptional scientists dedicated to halting the progression of genetic neuromuscular diseases.
Our lead program has the potential to deliver lifelong benefits for patients with Duchenne, a devastating muscle disease in children for which there is no cure. We combine creative innovation, rigorous science, teamwork, and a passionate commitment to developing transformative treatments for patients. Join us.
Exonics is proud to be an equal opportunity workplace.